A groundbreaking study reveals that microglia, the brain’s innate immune cells, may actively contribute to the formation of amyloid plaques associated with Alzheimer’s disease, rather than solely serving as defenders against them. Researchers found that microglia can maladaptively produce amyloid-β aggregates while attempting to clear existing plaques, challenging the prevailing view that these cells only facilitate cleanup.

This finding has significant implications for the understanding of neurodegenerative diseases, particularly in the context of aging. The study suggests that microglia may play a dual role, exacerbating plaque formation through a seeding mechanism that transforms soluble amyloid-β into more harmful fibrils. This insight shifts the focus from merely targeting microglial inflammation to considering their pathological contributions in the early stages of Alzheimer’s.

For longevity professionals, this research underscores the need to reevaluate therapeutic strategies aimed at microglial activity. I encourage you to explore the full article for a deeper understanding of these findings and their potential impact on Alzheimer’s research.

Source: fightaging.org